Could a common drug ease swallowing trouble in brain disorders?
NCT ID NCT05551182
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether nicergoline, a drug that improves blood flow in the brain, can help people with swallowing problems caused by stroke, Parkinson's disease, or dementia. 92 adults were given either a low or high dose for 12 weeks. The goal was to see if swallowing improved and to find the best dose with the fewest side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSPHAGIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Phramongkutklao Hospital
Ratchathewi, Bangkok, 10400, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which is safer for frail seniors: sedation or no sedation during feeding tube placement?
- Breathing exercises may retrain swallowing in ICU survivors — a trial puts it to the test
- Zapping the brain to restore swallowing after stroke
- Simple chin and neck exercises put to the test for MS swallowing problems
- Fewer heart scans during lung transplant may ease swallowing after surgery
- Could better nutrition care transform recovery for older mental health patients?